In addition, enhanced apoptosis and reduced cell proliferation were detected upon si-RNA mediated RICTOR knockdown and simultaneous treatment with sorafenib in CCA (Ding et al., 2016). This evidence concerns the gene RICTOR and cholangiocarcinoma.